Results 1 to 10 of about 333 (71)

Private Label: o potencial impacto no mercado de medicamentos no Brasil

open access: yesRevista de Economia Mackenzie
The objective of this article is to discuss how the release of private labels would change the dynamics of the industry with the eventual concentration of the retailer’s power in the medicines market. To this end, important theoretical aspects will be raised, based, for example, on Michael Porter’s theory (Five Competitive Forces and Value Chain). As a
Ronaldo Raemy Rangel   +2 more
openaire   +2 more sources

[Disease, social, and economic burden of smoking in Brazil and the impact of tax increases on the economy and on the reduction of morbidity and mortality]. [PDF]

open access: yesCad Saude Publica
Pinto M   +13 more
europepmc   +1 more source

Prices paid for primary health care medicines by Brazilian municipalities. [PDF]

open access: yesRev Saude Publica
Silva WROD   +5 more
europepmc   +1 more source

Prevalence and factors associated with self-medication among schoolchildren in the Metropolitan Region of Vitória, Brazil. [PDF]

open access: yesRev Esc Enferm USP
Mairink KR   +6 more
europepmc   +1 more source

Consumption of drugs for Alzheimer's disease on the Brazilian private market. [PDF]

open access: yesRev Saude Publica, 2023
Freitas EL   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy